How have AIMD and CNSP total returns compared?

Over the past 5 years, AIMD delivered -58.50% and CNSP delivered -91.63% annualized total return. Past performance doesn't predict future results.

Ainos, Inc. (AIMD) vs CNS Pharmaceuticals, Inc. (CNSP)

A side-by-side comparison of Ainos, Inc. and CNS Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AIMD

Ainos, Inc.

$10M

$1.29HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

CNSP

CNS Pharmaceuticals, Inc.

$8M

$5.30HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AIMD vs CNSP

growth of $100 · dividends reinvested · last 6y

AIMD -97.7% (-46.6%/yr)CNSP -100.0% (-87.8%/yr)AIMD compounded faster over this window

Log scale — wide-divergence pair

AIMD CNSP

AIMD vs CNSP: by the numbers

•AIMD is the larger company ($10M vs $8M market cap).
•Both run net losses; CNSP's is the smaller (0.00% vs -106283.32% net margin).

Metrics side by side

Valuation

Metric	AIMD	CNSP
P/S ratio	698.55	N/A
P/B ratio	2.89	0.43

Profitability

Metric	AIMD	CNSP
Gross margin	-3767.20%	0.00%
Operating margin	-11268.32%	0.00%
Net margin	-106283.32%	0.00%
ROE	-440.15%	-91.75%
ROIC	-80.51%	-92.94%

Growth (annualized)

Metric	AIMD	CNSP
Revenue CAGR (5Y)	49.62%	N/A
Total return CAGR (5Y)	-58.50%	-91.63%

Frequently asked

How have AIMD and CNSP total returns compared?: Over the past 5 years, AIMD delivered -58.50% and CNSP delivered -91.63% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AIMD analysis Full CNSP analysis Interactive comparison tool

Dig into the metrics

Ainos ROE CNS Pharmaceuticals ROE Ainos operating margin CNS Pharmaceuticals operating margin Ainos revenue growth CNS Pharmaceuticals revenue growth Ainos free cash flow CNS Pharmaceuticals free cash flow

Ainos & CNS Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.